Author

Azmi Aziz

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Behnia AkbariiD· 1 shared Erdem M. TerziiD· 1 shared Gregory FrancisiD· 1 shared Kameng Wu· 1 shared Kenji Mark FujiharaiD· 1 shared Maria Gutierrez-Perez· 1 shared Michael E. PacoldiD· 1 shared Nicholas James ClemonsiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Behnia AkbariORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systematic Evaluation Defines the Limits of Ferroptosis in Cancer Therapy

Kenji Mark Fujihara, Azmi Aziz, Behnia Akbari, Maria Gutierrez-Perez, Gregory Francis, Siham Zentout, Kameng Wu, Nicholas James Clemons, Erdem M. Terzi, Michael E. Pacold, Richard Possemato

This study evaluates ferroptosis induction in cancer therapy, finding that GPX4 inhibition fails to impact tumor growth, while cystine deficiency triggers non-ferroptotic cell death.

bioRxiv · Mar 14, 2026 · PreprintCancer Biology